FDA Drug Application (021444) for RISPERDAL by JANSSEN PHARMS

Back to FDA Applications sponsored by JANSSEN PHARMS

Application Number021444
Product Number001
FormTABLET, ORALLY DISINTEGRATING;ORAL
Dosage0.5MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameRISPERDAL
Active IngredientRISPERIDONE



Back to FDA Applications sponsored by JANSSEN PHARMS

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.